November 26th 2019: Antimicrobial Resistance; Why Is AMR Important? |eCard

SIGN-UP NOW! Click to become a The VoiceAmerica Talk Member for Free!

C. diff. Spores and More

Tuesday at 10 AM Pacific

November 26th 2019: Antimicrobial Resistance; Why Is AMR Important?

Join Our Guests: Kerrie Davies, Principal Clinical Scientist, and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds, and Dr. Jane Freeman, Clinical Scientist and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds. HEE/NIHR ICA Clinical Lecturer as they discuss Antimicrobial Resistance.--the who, what, how, and why of AMR and the importance of this topic. You won't want to miss this episode -Antibiotic Resistance is everyone's business!

DOWNLOAD PDF

GET CODE

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel

LISTEN LIVE

EPISODE ON DEMAND

VIEW HOST PAGE

Questions? Comments?
Call In Live! Call-In
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guests

Kerrie Davies

Kerrie Davies, Principal Clinical Scientist and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and University of Leeds. Kerrie has been a researcher for >20 years with a particular interest in Clostridium difficile laboratory diagnosis and was the lead scientist for the study that changed the UK C. difficile laboratory diagnostic guidelines, and has gone on to influence both the European (ESCMID) and US (SHEA) guidelines. Kerrie continues to study CDI diagnosis and is continually evaluating new and developing methods. In addition, Kerrie leads and coordinates several pan-European surveillance studies of CDI and is currently a co-investigator and the scientific lead for COMBAC

Read more

Dr. Jane Freeman

Dr. Jane Freeman, Clinical Scientist and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds. HEE/NIHR ICA Clinical Lecturer. Jane has >20 years’ experience in many aspects of C. difficile research. Jane's research interests are AMR in C. difficile, gut dysbiosis and paediatric CDI (C. diff. infection). She led the pan-European ClosER study – the largest study of C. difficile AMR to date. Jane established and developed the highly successful in vitro gut model of C. difficile infection at Leeds, that have enhanced our understanding of the effects of antimicrobials on C. difficile and gut microbiota, and AMR development. Jane and colleagues are currently w

Read more

Share This Episode

Share On Facebook

Share On Twitter

Share On LinkedIn

Share this E-mail

https://www.voiceamerica.com/show/2441/c-diff-spores-and-more 29/04/2024 08:00 29/04/2024 09:00 C. diff. Spores and More https://www.voiceamerica.com/show/2441/c-diff-spores-and-more Join Our Guests: Kerrie Davies, Principal Clinical Scientist, and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds, and Dr. Jane Freeman, Clinical Scientist and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds. HEE/NIHR ICA Clinical Lecturer as they discuss Antimicrobial Resistance.--the who, what, how, and why of AMR and the importance of this topic. You won't want to miss this episode -Antibiotic Resistance is everyone's business! VoiceAmerica | Talk Radio | Online Talk Radio studio@voiceamerica.com false DD/MM/YYYY

Add to Calendar

Email the Host

Connect with VoiceAmerica

Download our mobile apps